Q4 2023 Relmada Therapeutics Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Relmada Therapeutics, Inc. Fourth Quarter and Full Year 2022 Results Call. At this time, all lines are in a listen only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call, a recording needed assistance, please press star zero for the operator, and this call is being recorded on Tuesday, March 19th, 2024.
I would now like to turn the conference over to Tim McCarthy. Thank you. Please go ahead.
Thank you, operator, and thank you all for joining us this afternoon. With me on today's call are Chief Executive Officer, Sergio Traversa; and Chief Financial Officer, Maged Shenouda. This afternoon Relmada issued a press release providing a business update announcing financial results for the three and 12 months ended December 31st, 2023.
Please note that certain information discussed on the call today is covered under the Safe Harbor provisions of the Private Securities
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
